BR112012022775A2 - composições para a lavagem, do cólon e métodos para a produção e utilização das mesmas - Google Patents

composições para a lavagem, do cólon e métodos para a produção e utilização das mesmas

Info

Publication number
BR112012022775A2
BR112012022775A2 BR112012022775A BR112012022775A BR112012022775A2 BR 112012022775 A2 BR112012022775 A2 BR 112012022775A2 BR 112012022775 A BR112012022775 A BR 112012022775A BR 112012022775 A BR112012022775 A BR 112012022775A BR 112012022775 A2 BR112012022775 A2 BR 112012022775A2
Authority
BR
Brazil
Prior art keywords
colon cleansing
compositions
producing
methods
colon
Prior art date
Application number
BR112012022775A
Other languages
English (en)
Inventor
Sergio Baroni
Original Assignee
Nogra Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nogra Pharma Ltd filed Critical Nogra Pharma Ltd
Publication of BR112012022775A2 publication Critical patent/BR112012022775A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Abstract

composições para a lavagem do cólon e métodos para a produção e utilização das mesmas são apresentadas aqui composições que incluem polietileno glicol; sulfato alcalino metálico; e eletrólitos escolhidos do grupo que consiste de bicabornato de sólido, cloreto de sódio , e cloreto de potássio ou uma mistura dos mesmos , e uma composição corante gastro-protegida constítuida por um protetor gastro e um corante adequado para uso em um procedimento de exame do cólon. são apresenteados aqui sachês que incluem as composições apresentadas; conjuntos para a limpeza do cólon , e soluções aquosas adequadas para a limpeza do cólon.
BR112012022775A 2010-03-10 2011-03-10 composições para a lavagem, do cólon e métodos para a produção e utilização das mesmas BR112012022775A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10425061 2010-03-10
US35611110P 2010-06-18 2010-06-18
PCT/EP2011/001183 WO2011110347A2 (en) 2010-03-10 2011-03-10 Compositions for colon lavage and methods of making and using same

Publications (1)

Publication Number Publication Date
BR112012022775A2 true BR112012022775A2 (pt) 2016-07-19

Family

ID=44486085

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012022775A BR112012022775A2 (pt) 2010-03-10 2011-03-10 composições para a lavagem, do cólon e métodos para a produção e utilização das mesmas

Country Status (7)

Country Link
US (1) US20130121916A1 (pt)
EP (1) EP2544723A2 (pt)
AU (1) AU2011226324B2 (pt)
BR (1) BR112012022775A2 (pt)
CA (1) CA2792647A1 (pt)
MX (1) MX2012010482A (pt)
WO (1) WO2011110347A2 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
JP5889273B2 (ja) * 2010-04-01 2016-03-22 メディカル・テクロノジー・トランスファー・ホールディング・ベー・フェー 染色組成物
NZ607043A (en) 2010-08-04 2015-05-29 Borody Thomas J Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
WO2012122478A1 (en) 2011-03-09 2012-09-13 Regents Of The University Of Minnesota Compositions and methods for transplantation of colon microbiota
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
US9719144B2 (en) 2012-05-25 2017-08-01 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
ES2909386T3 (es) 2012-09-11 2022-05-06 Norgine Bv Composiciones que comprenden polietilenglicol y sulfatos de metales alcalinos o alcalinotérreos para su uso como composiciones de limpieza de colon
RS59667B1 (sr) 2013-03-15 2020-01-31 Braintree Laboratories Inc Oralna farmaceutska kompozicija sulfatnih soli u obliku tableta dvostruke primene i postupci njihove upotrebe
CN103272004B (zh) * 2013-05-24 2015-06-03 李兴如 用于动物健胃通便的中药组合物及其制备方法
CN103550212A (zh) * 2013-11-03 2014-02-05 王显著 含匹可硫酸和抗坏血酸的药物组合物
US10124074B2 (en) 2014-02-26 2018-11-13 Toufic Kachaamy Indirect chromoendoscopy with an oral indigo carmine base preparation
MX2017014488A (es) 2015-05-14 2018-06-11 Crestovo Holdings Llc Composiciones para transplante de la flora fecal y metodos para elaborarlos y utilizarlos y dispositivos para suministrarlos.
DK3297644T3 (da) 2015-05-22 2022-04-11 Univ Arizona State Fremgangsmåder til behandling af autismespektrumforstyrrelse og forbundne symptomer
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11213549B2 (en) 2016-10-11 2022-01-04 Finch Therapeutics Holdings Llc Compositions and method for treating primary sclerosing cholangitis and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
CA3058818A1 (en) 2017-04-05 2018-10-11 Crestovo Holdings Llc Compositions and methods for treating parkinson's disease (pd) and related disorders
WO2018187464A1 (en) 2017-04-05 2018-10-11 Crestovo Holdings Llc Compositions and methods for treating diverticulitis and related disorders
AU2018272048B2 (en) 2017-05-26 2024-04-04 Finch Therapeutics Holdings Llc Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
CA3072032A1 (en) 2017-08-07 2019-02-14 Finch Therapeutics, Inc. Compositions and methods for maintaining and restoring a healthy gut barrier
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
KR20210065969A (ko) 2018-09-27 2021-06-04 핀치 테라퓨틱스 홀딩스 엘엘씨 간질 및 관련 장애를 치료하기 위한 조성물 및 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056609A (en) * 1976-01-28 1977-11-01 Gunn, Kirchubel & Miller Article for diagnosis of achlorhydria
DE2651918A1 (de) * 1976-11-13 1978-05-18 G Pohl Boskamp Fa Verfahren zur herstellung von magensaeuretestdragees
US4948586A (en) * 1987-11-02 1990-08-14 Lim Technology Laboratories, Inc. Microencapsulated insecticidal pathogens
US5422121A (en) * 1990-11-14 1995-06-06 Rohm Gmbh Oral dosage unit form
US7122207B2 (en) * 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition
PE20001302A1 (es) * 1998-11-27 2000-11-30 Hoffmann La Roche Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida
US7838037B2 (en) * 1999-11-17 2010-11-23 Tagra Biotechnologies Ltd. Method of microencapsulation
AU2001211213A1 (en) * 2000-10-20 2002-04-29 Galephar M/F Stable oral formulation containing benzimidazole derivative
IL155959A0 (en) * 2000-11-28 2003-12-23 Fmc Corp Edible pga (propylene glycol alginate) coating composition
GB0110846D0 (en) * 2001-05-02 2001-06-27 Phoqus Ltd Tablets with coloured patterns
GB0117619D0 (en) * 2001-07-19 2001-09-12 Phoqus Ltd Pharmaceutical dosage form
DE10239999A1 (de) * 2002-08-27 2004-03-04 Röhm GmbH & Co. KG Granulat oder Pulver zur Herstellung von Überzugs- und Bindemitteln für Arzneiformen
GB0224909D0 (en) * 2002-10-25 2002-12-04 Norgine Europe Bv Colon cleansing compositions
US20070020334A1 (en) * 2005-07-11 2007-01-25 Poul Bertelsen Benzimidazole formulation
BRPI0700969A (pt) * 2007-03-22 2008-11-04 Ouro Fino Participacoes E Empr composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia
ES2331501B1 (es) * 2007-11-14 2010-10-21 Blanver Farmoquimica, Ltda Composicion farmaceutica solida de didanosina.

Also Published As

Publication number Publication date
US20130121916A1 (en) 2013-05-16
EP2544723A2 (en) 2013-01-16
WO2011110347A2 (en) 2011-09-15
AU2011226324B2 (en) 2015-09-24
MX2012010482A (es) 2013-03-12
AU2011226324A1 (en) 2012-10-04
CA2792647A1 (en) 2011-09-15
WO2011110347A3 (en) 2012-01-12

Similar Documents

Publication Publication Date Title
BR112012022775A2 (pt) composições para a lavagem, do cólon e métodos para a produção e utilização das mesmas
BR112015018508A2 (pt) moduladores de enzimas modificadoras de metila, suas composições e uso
CY1122853T1 (el) Σταθερα σκευασματα λινακλοτιδης
EA201200153A1 (ru) Сухая композиция для смешивания с водой (варианты), раствор для очищения кишечника на ее основе, водный раствор, набор, способ очищения толстой кишки
BRPI0907663A2 (pt) ''composição que compreende hfo- 123 yf, composição que compreende hcfc-243db, composição que compreende hcfo- 1233xf, composição que comproeende hcfc- 244bb, uso das composições e método de uso das composições.
CR20110069A (es) Agentes de fijacion al receptor notch1 y metodos para el uso de los mismos
BR112013018352A2 (pt) composição de minociclina tópica e método
CL2011002943A1 (es) Anticuerpo triespecifico o tetraespecifico; metodo para la preparacion de dicho anticuerpo; celula huesped; composicion farmaceutica.
EA200970273A1 (ru) Применение 2-6-(3-аминопиперидин-1-ил)-3-метил-2,4-диоксо-3,4-дигидро-2н-пиримидин-1-илметил-4-фторбензонитрила
AR092487A2 (es) Anticuerpos contra la angiopoyetina 2 humana
EA201390145A1 (ru) Конъюгаты, частицы, композиции и связанные с ними способы
BR112013028907A2 (pt) conjugados de proteína-agente ativo e método para preparar os mesmos
BR112013017947A2 (pt) benzoazepinas substituídas como moduladores de receptor toll-like
BR112014032910A2 (pt) solfactants de éter de glicerina etoxilado
ECSP109917A (es) Nuevos derivados de ácido azabifenilaminobenzoico
BRPI0916884A2 (pt) composição imunogênica, processo para preparar uma composição imunogênica, uso de uma composição imunogênica, e, kit
CL2014002023A1 (es) Proceso para la preparación de una solución acuosa que comprende al menos un carbonato ácido alcalinoterreo y su uso.
CL2013001138A1 (es) Composicion que comprende anticuerpo biespecífico cd19xcd3 para tratar masa tumoral de tejido de ganglios linfáticos y/o linfoma extranodal causado por el linfoma b difuso de células grandes (lbdcg); kit farmacéutico; uso de la composición.
CL2012000401A1 (es) Metodo para hacer una composicion para producir un recubrimiento ultrahidrofobo que comprende combinar un primer solvente y las particulas las cuales no son solubles pero dispersables en primer solvente y combinar con segundo solvente, obtener composicion y recuperacion de la composicion; recubrimiento ultrahidrofobo; y composicion.
EA201291372A1 (ru) Фармацевтическая композиция, содержащая дроспиренон, и набор для предупреждения зачатия
BR112014009946A2 (pt) "composição, composição farmacêutica ou formulação purgativas e uso das mesmas"
EA201391523A1 (ru) Композиции и способы для переноса энергии митохондрий аутологичных герминативных клеток
AR074270A1 (es) Composicion de champu concentrada
CU24317B1 (es) Conjugado de naloxol-peg cristalino
EA201070009A1 (ru) Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]